Search results

460 items
  1. Amphetamine Type Stimulants and Harm Reduction

    • Tom Blickman
    01 October 2011
    Policy briefing

    Little is known about the methamphetamine market in the region, but there are strong indications that the situation is deteriorating with substances becoming stronger, methods of use more harmful and the number of users steadily increasing. There is an urgent need for donors and governments to introduce effective harm reduction measures.

  2. In Search of Rights

    • The Research Consortium on Drugs and the Law (CEDD)
    09 July 2014

    The Research Consortium on Drugs and the Law (Colectivo de Estudios Drogas y Derecho, CEDD) has published a new study that assesses state responses to illicitly-used drugs in eight countries in Latin America: Argentina, Brazil, Bolivia, Colombia, Ecuador, Mexico, Peru and Uruguay. The study found that Latin American governments’ approach to drug use continues to be predominantly through the criminal justice system, not health institutions. Even in countries where consumption is not a crime, persistent criminalization of drug users is common.

     

  3. Regional Overview of Drug Laws

    • Martin Jelsma
    11 March 2010
    Paper

    A country by country overview of drug law reform in the Latin American region.

  4. Decriminalisation in Europe?

    • European Monitoring Centre for Drugs, Drug Addiction (EMCDDA)
    01 November 2001

    This brief report analyses the similarities and differences in legal attitudes to drug use and possession across Europe in light of the recent changes in 2001.

  5. Khat use in Europe

    01 July 2011
    Khat leaves are cultivated in the highlands of the Horn of Africa, Southern Arabia and along the East African coast. In many countries, chewing khat is an age-old tradition. More recently, the mass migration of people from the Horn of Africa has been associated with the spread of khat usage to neighbouring countries, Europe and the rest of the world. Exact numbers of regular khat users on a worldwide scale do not exist, however estimates range up to 20 million. This paper presents the challenges associated with the spread of khat consumption.
  6. Thumbnail

    Decriminalisation in Europe?

    • European Monitoring Centre for Drugs, Drug Addiction (EMCDDA)
    01 November 2001

    decrim-europeThis brief report analyses the similarities and differences in legal attitudes to drug use and possession across Europe in light of the recent changes in 2001.

    application-pdfDownload the document (PDF)

  7. Cannabis: Classification and Public Health

    01 April 2008
    Report

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  8. Cannabis policy reform in Europe

    • Tom Blickman
    21 December 2014
    Policy briefing

    While in the Americas cannabis policy reform is taking off, Europe seems to be lagging behind. At the level of national governments denial of the changing policy landscape and inertia to act upon calls for change reigns. At the local level, however, disenchantment with the current cannabis regime gives rise to new idea.

  9. Cannabis: Classification and Public Health

    01 April 2008

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  10. Cannabis production and markets in Europe

    26 June 2012

    This study brings together available evidence to provide a comprehensive analysis of cannabis production and markets across the EU. It combines information from EMCDDA routine reporting — data on patterns of prevalence and use, seizures, police reports, drug-law offences, cannabis potency and retail market prices — with literature on cannabis markets to create an in-depth analysis of the issue in a European context.

     

  11. publication

    Use of Narcotic Drugs in Public Injection Rooms under Public International Law

    07 January 2000

    State-controlled public injection rooms are not expressly referred to in any of the rele­vant international conventions. It is thus necessary to determine, by way of a prelimi­nary factual enquiry, the exact characteristics of such institutions that fall within the ambit of one or more of the conventions. The rather superficial provisions concerning drug addicts stand in stark contrast to the stated primary aims of the conventions, which are formulated in the preambles as pre­venting and combatting abuse of narcotic drugs and psychotropic substances and the public health and social problems which such abuse engenders.

  12. 2009 Global Forum of Producers of Crops Declared to be Illicit

    30 January 2009

    Why peasants from certain regions of the world cultivate the three plants – coca leaves, cannabis and opium poppy – that the international conventions have declared to be illicit? That was the essential question that was discussed at the First Global Forum of Producers of Crops Declared to be Illicit (FMPCDI), that took place in El Prat de Llobregat near Barcelona on January 29-31, 2009.

  13. Trends in Drug Law Reform in Europe and Latin America

    • Martin Jelsma
    26 January 2010

    This presentation gives a short overview of legislative reforms in Europe and Latin America that provide lessons learned in practice about less punitive approaches intended to reduce drug-related harm to the individual and society.  Evidence suggests that fears that softening drug laws and their enforcement would lead to sharp increases in drug use, have proven untrue.

     

  14. Trends in Drug Law Reform in Europe and Latin America

    • Martin Jelsma
    11 March 2010
    Paper

    Presentation at the Thai Office of the Narcotics Control Board - ONCB Bangkok, 26 January 2010

  15. How well do international drug conventions protect public health?

    • Robin Room, Peter Reuter (RAND)
    07 January 2012

    The Single Convention on Narcotic Drugs in 1961 aimed to eliminate the illicit production and non-medical use of cannabis, cocaine, and opioids, an aim later extended to many pharmaceutical drugs. Over the past 50 years international drug treaties have neither prevented the globalisation of the illicit production and non-medical use of these drugs, nor, outside of developed countries, made these drugs adequately available for medical use.

  16. coverexpertseminar

    Expert Seminar: Where next for Europe on drug policy reform?

    04 October 2013

    The expert seminar “Where next for Europe on drug policy reform?” analysed the new EU strategy on drugs and its action plan and discussed ways to improve and innovate European drug policy. The seminar comprised of four major sessions : the EU Drugs Strategy and Action Plan and its public health implications; the EU Drugs Strategy and Action Plan and its law enforcement implications; regional challenges and the issue of new psychoactive substances; the role of Europe in global drug policy and the European voice in preparation for the 2016 UNGASS. This report also contains the key note speech presented by the former President of Portugal, Jorge Sampaio.

  17. cannabis-europe

    Expert Seminar: Costs and benefits of cannabis regulation models in Europe

    30 October 2013

    The Transnational Institute (TNI) organized an expert seminar on Costs and Benefits of Cannabis Regulation Models in Europe in Amsterdam, The Netherlands on October 31/November 1, 2013. The objective of the seminar was to identify and map existing and possible future cannabis regulation models in Europe, looking at the local, provincial and national levels and the po­tential impact of such models on the illicit cannabis market.

  18. Modernising the global drug control system – Can Europe lead?

    28 May 2012
    Report

    The seminar entitled “Modernising the global drug control system – Can Europe lead?” was organised in the European Parliament by the International Drug Policy Consortium (IDPC), and the Global Commission on Drug Policy, and co-hosted by the Member of European Parliament (MEP) Nikos Chrysogelos. The event aimed to present the recommendations of the Global Commission and discuss the role that the European Union (EU) could play in current drug policy reform debates taking place within Europe and around the world. The seminar also comes at a time when the EU is working on drafting a new Drug Strategy to replace the one that will expire at the end of 2012.

  19. Legal Responses to New Psychoactive Substances in Europe

    • Brendan Hughes, T Blidaru
    19 February 2009

    This paper starts from the premise that, when a new psychoactive substance appears on the licit/illicit market in a country in Europe, legislators need to choose whether to bring it under control of the drug laws, and for public health reasons they may need to do so quickly. A comparative study of the systems and procedures finds that there are a variety of control methods available in the different countries, including the analogue and generic systems, as well as temporary emergency and rapid permanent scheduling procedures.

     

  20. Khat use and monitoring drug use in Europe

    • Paul Griffiths, Dominique Lopez, Roumen Sedefov, Ana Gallegos, Brendan Hughes, André Noor, Luis Royuela
    07 May 2010

    The aim of the study was to review the information available on the use of khat (Catha edulis) in the EU, and to assess the future use of this drug and related substances. Khat use sits awkwardly within the current EU reporting framework, and this hampers the production of a European-level analysis of the use of this drug. Why this is so, and what information is available at the European level, are the topics addressed in this paper. The analysis is extended to consider if the current evidence suggests that this drug, or synthetic variations of the psychoactive compounds it contains, are likely to play a greater role in the European drug scene of the future.

    Download the article (PDF)

Pages